Molecular Diagnostics
Develop and evaluate diagnostics with world-leading experts from Liverpool School of Tropical Medicine
About
iiDX supports collaborators to design, develop, evaluate, and validate novel diagnostic technologies.
It offers industry access to world-leading expertise and facilities at Liverpool School of Tropical Medicine, supporting the product development journey from early-stage concept through prototype evaluation and regulatory approval.
World-Leading Diagnostic
UK Diagnostic Evaluation and Containment Testing Facility
This is the UK diagnostic evaluation testing site for Foundation for Innovative New Diagnostics (FIND) which informs the World Health Organisation (WHO) on procurement and policy decisions. It also has access to the largest Containment Level 3 laboratories in the North West; able to work with hazardous pathogens such as SARS-CoV-2, Mpox, Mycobacterium and Influenza.
iiDX works with industry using FDA approved protocols to assess analytical and clinical sensitivity and specificity and efficacy in real-world settings. Collaborators benefit from a broad diagnostic focus and expertise across a range of platforms including antibody and antigen detection (ELISA, lateral flow test, microfluidics), culture and molecular testing (qPCR, LAMP, portable platforms).
